PubHawk
Adv Ther May 2020 PMID 32227306

A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries Outside Western Europe and North America.

Ashraf Reda, Wael Almahmeed, Idit Dobrecky-Mery, Po-Hsun Huang, Ursulo Juarez-Herrera, Naresh Ranjith, Tobias Sayre, Miguel Urina-Triana

Download social card

Mentions

4
Peak: 2 in Apr 2020
across 2 sources since Apr 2020

Extended reach

27,977
potential audience

Total likes

3

Video views

126

Mentions per month

Apr 2020 – May 2021

Where it's discussed

  • X / Twitter3 posts
  • YouTube1 videos

AI synopsis

What people are saying

Discussions emphasize the relevance of the article by mentioning awareness campaigns like #NationalLipidDay and sharing references to expert recommendations, with words like 'highlight,' 'barriers,' and 'recommendations' reflecting a view that the publication could lead to meaningful improvements in dyslipidaemia care in underserved regions.

AgreementModerate agreement

Most discussions acknowledge the importance of the article's focus on improving dyslipidaemia management outside Western regions.

InterestHigh interest

Posts show high enthusiasm and curiosity, especially with mentions of national health days and specific guidelines.

EngagementModerate engagement

The comments demonstrate moderate engagement, including sharing summaries and retweeting, indicating an active interest.

ImpactModerate impact

The focus on barriers and recommendations suggests that readers perceive this publication as potentially influential in shaping healthcare practices.

Abstract in brief

  • This review highlights that patients who experience an acute coronary syndrome (ACS) are at high risk for future heart-related events, but managing their cholesterol levels outside Western Europe and North America is often ineffective despite available treatments and guidelines.
  • Challenges in these regions include higher prevalence of risk factors, earlier onset of ACS, low awareness of the importance of intensive lipid lowering, physician nonadherence to guidelines, and limited access to appropriate medications and follow-up care.
  • To improve outcomes, the review suggests adopting country-specific treatment strategies, enhancing medical education, and prioritizing dyslipidaemia management within healthcare systems to help more patients reach LDL cholesterol targets.
Read the full abstract

Top posts

Most liked on X and Bluesky
Juan Senior
@jsenior64 · X

A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries Outside Western Europe and North America https://t.co/5JUVevXtWK

Apr 1, 2020 · 3 likes · 2 shares · 11,090 followers View post →
Research Square
@researchsquare · X

In honor of #NationalLipidDay, we're sharing this @AdvancesTherapy review, which outlines recommendations made by an expert panel examining barriers to #dyslipidemia management in countries outside Europe and North America: https://t.co/BdbR65YL4N https://t.co/p7b2iiGfBe

May 10, 2021 · 16,556 followers View post →

All mentions

Research Square
@researchsquare · X

In honor of #NationalLipidDay, we're sharing this @AdvancesTherapy review, which outlines recommendations made by an expert panel examining barriers to #dyslipidemia management in countries outside Europe and North America: https://t.co/BdbR65YL4N https://t.co/p7b2iiGfBe

May 10, 2021 · 16,556 followers View post →
Dr. Miguel Urina-Triana
@MAUrinaTriana · X

RT @jsenior64: A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries O…

Apr 1, 2020 · 2 shares · 197 followers View post →
Juan Senior
@jsenior64 · X

A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries Outside Western Europe and North America https://t.co/5JUVevXtWK

Apr 1, 2020 · 3 likes · 2 shares · 11,090 followers View post →